Sign in
Taking people in United KingdomNo phase

Digital Tool Assesses Thinking Skills After Stroke and Related Brain Conditions

Tests a digital thinking-skills assessment and brain scans in adults with stroke.

Key facts

Who runs it
Imperial College London
Where
London, United KingdomSee the site
Trial code
Registry title
The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3)
Status
Recruiting
People taking part
700 people, planned
Started
1 Dec 2021
Expected to end
15 May 2028
Type of study
Observational, 2 groups
Treatments tested
  • MRI brain, Blood tests, cognitive assessments
Record updated
1 June 2023

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who have had a confirmed stroke, and also healthy adults as a comparison group. They take part in cognitive (thinking and memory) tests on a computer.

Age
Older than 18 years
Sex
All sexes can join
Disease stage
A confirmed stroke (for patients). The record names no stage or severity.

Main reasons for not taking part

  • A diagnosis of dementia before the stroke
  • Severe visuo-spatial problems, fatigue or mental health problems
  • Severe hearing impairment together with trouble understanding what they read
  • Cannot concentrate for 15 minutes at a time
  • For the MRI part only: pregnancy, metal implants or claustrophobia

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Aged > 18
  • Evidence of confirmed stroke (for patients)
  • Ability to concentrate for 15 minutes at a time to engage with cognitive testing

Who cannot take part

  • Presence of metal implants
  • Pre-stroke diagnosis of dementia
  • Severe hearing impairment in the presence of reading comprehension impairment
  • Severe visuo-spatial problems, fatigue, or mental health problems
  • Pregnancy
  • Claustrophobia

Where in United Kingdom

  • Imperial College LondonLondon, United KingdomContact: Fatemeh Geranmayeh, PhDTaking people

About the trial

What the trial wants to find out

Stroke is a major cause of death and disability worldwide, frequently resulting in persistent cognitive deficits among survivors. These deficits negatively impact recovery and therapy engagement, and their treatment is consistently rated as high priority by stakeholders and clinicians. Although clinical guidelines endorse cognitive screening for post-stroke management, there is currently no gold standard approach for identifying cognitive deficits after stroke, and clinical stroke services lack the capacity for long-term cognitive monitoring and care. Currently available assessment tools are either not stroke-specific, not in-depth or lack scalability, leading to heterogeneity in patient assessments. To address these challenges, a cost-effective, scalable, and comprehensive screening tool is needed to provide a stroke-specific assessment of cognition. The current study presents such a novel digital tool, the Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3), designed to detect both domain-general and domain-specific cognitive deficits in patients after stroke with minimal input from a health professional. To ensure its reliability, we will utilise multiple validation approaches, and aim to recruit a large normative sample of age-, gender-, and education-matched UK-based controls. Moreover, the IC3 assessment will be integrated within a larger prospective observational longitudinal clinical trial, where post-stroke cognition will be examined in tandem with brain imaging and blood biomarkers to identify novel multimodal biomarkers of recovery after stroke. By leveraging this rich dataset, our study will allow more precise targeting of cognitive rehabilitation to stroke survivors that are most at risk of progressive cognitive decline and have the greatest potential for recovery.

The 2 groups in the trial

  • Patient

    Patient with stroke

    Treatment: MRI brain, Blood tests, cognitive assessments

  • Controls

    Age-matched controls

    Treatment: MRI brain, Blood tests, cognitive assessments

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Understanding Factors Affecting Cognitive Function in Cerebrovascular Disease
Plain-language title
Digital Tool Assesses Thinking Skills After Stroke and Related Brain ConditionsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Publications
Record updated
1 June 2023